Бронхиальная астма и беременность

Обложка

Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Особенности течения и лечения бронхиальной астмы (БА) в период беременности в последние десятилетия являются предметом пристального внимания исследователей. Физиологические изменения и характер лечения БА во время беременности определяют степень контролируемости заболевания, которая, в свою очередь, влияет и на частоту развития осложнений беременности и родов, и на состояние здоровья новорожденного. В представленном обзоре литературы проведен анализ последних публикаций, посвященных этому вопросу.

Полный текст

Доступ закрыт

Об авторах

О. В. Лаврова

Первый Санкт-Петербургский государственный медицинский университет им. И.П. Павлова

Автор, ответственный за переписку.
Email: loverova@bk.ru

доктор медицинских наук

Россия

М. А. Петрова

Первый Санкт-Петербургский государственный медицинский университет им. И.П. Павлова

Email: loverova@bk.ru

доктор медицинских наук, профессор

Россия

Список литературы

  1. Wu T.D., Brigham E.P., McCormack M.C. Asthma in the Primary Care Setting. Med Clin North Am. 2019; 103 (3): 435–52. doi: 10.1016/j.mcna.2018.12.004
  2. Murphy V.E., Wang G., Namazy J.A. et al. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis. BJOG. 2013; 120 (7): 812–22. doi: 10.1111/1471-0528.12224
  3. Grosso A., Locatelli F., Gini E. et al. The course of asthma during pregnancy in a recent, multicase-control study on respiratory health. Allergy Asthma Clin Immunol. 2018; 14: 16. doi: 10.1186/s13223-018-0242-0
  4. Namazy J.A., Schatz M. Contemporary management and treatment strategies for asthma during pregnancy. Expert Rev Respir Med. 2021; 15 (9): 1149–57. doi: 10.1080/17476348.2021.1935243
  5. Ibrahim W.H., Rasul F., Ahmad M. et al. Asthma knowledge, care, and outcome during pregnancy: The QAKCOP study. Chron Respir Dis. 2019; 16: 1479972318767719. doi: 10.1177/1479972318767719
  6. Tan E.K., Tan E.L. Alterations in physiology and anatomy during pregnancy. Best Pract Res Clin Obstet Gynaecol. 2013; 27 (6): 791–802. doi: 10.1016/j.bpobgyn.2013.08.001
  7. Annamraju H., Mackillop L. Respiratory disease in pregnancy. Obstet Gynaecol Reprod Med. 2017; 27 (4): 105–11. doi: 10.1016/j.ogrm.2017.01.011
  8. Mehta N., Chen K., Hardy E. et al. Respiratory disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015; 29 (5): 598–611. doi: 10.1016/j.bpobgyn.2015.04.005
  9. Murphy V.E. Asthma in pregnancy Management, maternal co-morbidities, and long-term health. Best Pract Res Clin Obstet Gynaecol. 2022; 85 (Pt A): 4556. doi: 10.1016/j.bpobgyn.2022.06.005
  10. Kourtis A.P., Read J.S., Jamieson D.J. Pregnancy and infection. N Engl J Med. 2014; 370 (23): 2211–8. doi: 10.1056/NEJMra1213566
  11. National Asthma Council Australia. Australian asthma Handbook, 2019. Available at: https://www.asthmahandbook.org.au/populations/pregnant-women/preconception
  12. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2023. Available at: https://ginasthma.org/gina-reports
  13. Kher S., Mota P. Maternal asthma: Management strategies. Cleve Clin J Med. 2017; 84 (3): 296–302. doi: 10.3949/ccjm.84a.15046
  14. van Nederveen-Bendien S.A., van Oord-Bosselaar S.R.J. Pharmacological treatment of asthma during pregnancy. Ned Tijdschr Geneeskd. 2018; 162: D2099.
  15. Wang H., Li N., Huang H. Asthma in Pregnancy: Pathophysiology, Diagnosis, Whole-Course Management, and Medication Safety. Can Respir J. 2020; 2020: 9046842. doi: 10.1155/2020/9046842
  16. Robijn A.L., Murphy V. E., Gibson P.G. Recent developments in asthma in pregnancy. Curr Opin Pulm Med. 2019; 25 (1): 11–7. doi: 10.1097/MCP.0000000000000538
  17. Stoup T., Chenivesse C. Management of asthma during pregnancy. Rev Mal Respir. 2021; 38 (6): 626–37. doi: 10.1016/j.rmr.2021.04.010
  18. Blais L., Beauchesne M.F., Lemière C. et al. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. Allergy Clin Immunol. 2009; 124 (6): 1229–34.e4. doi: 10.1016/j.jaci.2009.09.025
  19. Cossette B., Forget A., Beauchesne M.-F. et al. Impact of maternal use of asthma-controller therapy on perinatal outcomes. Thorax. 2013; 68 (8): 724–30. doi: 10.1136/thoraxjnl-2012-203122
  20. Palmsten K., Bandoli G., Vazquez-Benitez G. et al. Oral corticosteroid use during pregnancy and risk of preterm birth. Rheumatology (Oxford). 2020; 59 (6): 1262–71. doi: 10.1093/rheumatology/kez405
  21. Namazy J. A., Murphy V. E., Powell H. et al. Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes. Eur Respir J. 2013; 41 (5): 1082–90. doi: 10.1183/09031936.00195111
  22. Martel M.-J., Rey É., Beauchesne M.-F. et al. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ. 2005; 330 (7485): 230. doi: 10.1136/bmj.38313.624352.8f
  23. Zhang D., Liu H., Zeng J. et al. Glucocorticoid exposure in early placentation induces preeclampsia in rats via interfering trophoblast development. Gen Comp Endocrinol. 2016; 225: 61–70. doi: 10.1016/j.ygcen.2015.09.019
  24. Eltonsy S., Kettani F.-Z., Blais L. Beta2-agonists use during pregnancy and perinatal outcomes: a systematic review. Respir Med. 2014; 108 (1): 9–33. doi: 10.1016/j.rmed.2013.07.009
  25. Garne E., Hansen A. V., Morris J. et al. Use of asthma medication during pregnancy and risk of specific congenital anomalies: a European case-malformed control study. J Allergy Clin Immunol. 2015; 136 (6): 1496–502. doi: 10.1016/j.jaci.2015.05.043
  26. Blais L., Kettani F.-Z., Forget A. et al. Long-acting β2-agonists and risk of hypertensive disorders of pregnancy: a cohort study. J Allergy Clin Immunol. 2018; 6 (2): 555–61. doi: 10.1016/j.jaip.2017.07.004
  27. Soler X., Ramsdell J. Anticholinergics/antimuscarinic drugs in asthma. Curr Allergy Asthma Rep. 2014; 14 (12): 484. doi: 10.1007/s11882-014-0484-y
  28. Quirce S., Dominguez-Ortega J., Barranco P. Anticholinergics for treatment of asthma. J Investig Allergol Clin Immunol. 2015; 25 (25): 84–5.
  29. Rocklin R.E. Asthma, asthma medications and their effects on maternal/fetal outcomes during pregnancy. Reprod Toxicol. 2011; 32 (2): 189–97. doi: 10.1016/j.reprotox.2011.05.023
  30. Castillo J.R., Peters S.P., Busse W.W. Asthma exacerbations: pathogenesis, prevention, and treatment. J Allergy Clin Immunol. 2017; 5 (4): 918–27. doi: 10.1016/j.jaip.2017.05.001
  31. Tamada T., Ichinose M. Leukotriene Receptor Antagonists and Antiallergy Drugs. Handb Exp Pharmacol. 2017; 237: 153–69. doi: 10.1007/164_2016_72
  32. Nelsen L.M., Shields K.E., Cunningham M.L. et al. Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications. J Allergy Clin Immunol. 2012; 129 (1): 251–4. doi: 10.1016/j.jaci.2011.09.003
  33. Kiernan E., Jones K.L. Medications that cause fetal anomalies and possible prevention strategies. Clin Perinatol. 2019; 46 (2): 203–13. doi: 10.1016/j.clp.2019.02.003
  34. Namazy J., Cabana M.D., Scheuerle A.E. et al. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol. 2015; 135 (2): 407–12. doi: 10.1016/j.jaci.2014.08.025
  35. Kelly W., Massoumi A., Lazarus A. Asthma in pregnancy: physiology, diagnosis, and management. Postgrad Med. 2015; 127 (4): 349–58. doi: 10.1080/00325481.2015.1016386
  36. Sattler C., Garcia G., Humbert M. Novel targets of omalizumab in asthma. Curr Opin Pulm Med. 2017; 23 (1): 56–61. doi: 10.1097/mcp.0000000000000340
  37. Bel E.H., Wenzel S.E., Thompson P.J. et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014; 371 (13): 1189–97. doi: 10.1056/nejmoa1403291
  38. Castro M., Mathur S., Hargreave F. et al. Reslizumab for poorly controlled, eosinophilic asthma. Am J Resp Crit Care Med. 2011; 184 (10): 1125–32. doi: 10.1164/rccm.201103-0396oc
  39. Abramowicz M., Zuccotti G., Pflomm J.M. Benralizumab (Fasenra) for severe eosinophilic asthma. JAMA. 2018; 319 (14): 1501–2. doi: 10.1001/jama.2018.3609
  40. Pitsios C., Demoly P., Bilò M. B. et al. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015; 70 (8): 897–909. doi: 10.1111/all.12638
  41. Shaikh W.A., Shaikh S.W. A prospective study on the safety of sublingual immunotherapy in pregnancy. Allergy. 2012; 67 (6): 741–3. doi: 10.1111/j.1398-9995.2012.02815.x
  42. Murphy V.E., Jensen M.E., Gibson P.G. Asthma during Pregnancy: Exacerbations, Management, and Health Outcomes for Mother and Infant. Semin Respir Crit Care Med. 2017; 38 (2): 160–73. doi: 10.1055/s-0037-1600906
  43. Shebl E., Chakraborty R.K. Asthma in Pregnancy. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023.
  44. Бронхиальная астма. Клинические рекомендации. 2021 [Bronkhial'naya astma. Klinicheskie rekomendatsii. 2021 (in Russ.)]. URL: https://spulmo.ru/upload/kr/BA_2021.pdf
  45. Ali Z., Nilas L., Ulrik C.S. Determinants of low risk of asthma exacerbation during pregnancy. Clin Exp Allergy. 2018; 48 (1): 23–8. doi: 10.1111/cea.13033
  46. Murphy V.E., Powell H., Wark P.A.B. et al. A prospective study of respiratory viral infection in pregnant women with and without asthma. Chest. 2013; 144 (2): 420–7. doi: 10.1378/chest.12-1956
  47. Majithia R., Johnson D.A. Are proton pump inhibitors safe during pregnancy and lactation? Evidence to date. Drugs. 2012; 72 (2): 171–9. doi: 10.2165/11597290-000000000-0000
  48. Marchi J., Berg M., Dencker A. et al. Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews. Obes Rev. 2015; 16 (8): 621–38. doi: 10.1111/obr.12288

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ИД "Русский врач", 2024

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах